Key clinical point: Transplant type was identified as an independent risk factors for improved overall survival (OS).
Major finding: Auto stem cell transplantation (SCT) showed improved OS: HR 0.35, P < .05, compared to allo SCT.
Study details: Single center study of 56 patients who underwent transplant as consolidation therapy for MCL.
Disclosures: Study funding, authors conflicts not reported.
Naik S et al. Biol Blood Marrow Transplant. 2020 26: S246-S247.